CLINICAL_TRIALS
trial_result
· 2024-12-19
Clinical Trial Update: A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome [Phase 2]
Summary
A Phase 2 two-period crossover trial of BPN14770 in adult males with Fragile X Syndrome has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tetra Discovery Partners | Conditions: Fragile X Syndrome, FXS | Phase 2 | Status: COMPLETED | Results posted: 2024-12-19